1. Home
  2. YAAS vs TCRT Comparison

YAAS vs TCRT Comparison

Compare YAAS & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youxin Technology Ltd

YAAS

Youxin Technology Ltd

HOLD

Current Price

$0.75

Market Cap

6.7M

Sector

Technology

ML Signal

HOLD

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$3.09

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YAAS
TCRT
Founded
2018
1998
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.7M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
YAAS
TCRT
Price
$0.75
$3.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
43.8K
11.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,900,000.00
Revenue This Year
N/A
$5,680,500.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$1.31
52 Week High
$7.00
$5.48

Technical Indicators

Market Signals
Indicator
YAAS
TCRT
Relative Strength Index (RSI) 14.58 56.32
Support Level $0.37 $2.89
Resistance Level $1.88 $3.73
Average True Range (ATR) 0.10 0.25
MACD -0.04 0.02
Stochastic Oscillator 2.76 62.86

Price Performance

Historical Comparison
YAAS
TCRT

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Share on Social Networks: